Madeleine King

University of Sydney — Australia

Economics, Econometrics and Finance · Social Sciences

81h-index22.2kcitations436works3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Health Systems, Economic Evaluations, Quality of Life(123), Cancer survivorship and care(117), Childhood Cancer Survivors' Quality of Life(55), Palliative Care and End-of-Life Issues(50), Ovarian cancer diagnosis and treatment(36)

Publications433 total

A cost comparison of radiotherapy and topical imiquimod for lentigo maligna treatment: Considerations for clinical decision-making
Journal of the American Academy of Dermatology·2025Open Access
Quality of life utility-Core 10 dimensions (QLU-C10D) scores based on cancer patients’ health preferences are more sensitive than those based on general public’s health preferences
The European Journal of Health Economics·2025
Japanese value set for the Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D) cancer-specific preference-based quality of life instrument
Health and Quality of Life Outcomes·2025Open Access
CN88 A phase II randomized trial of nurse led telehealth follow-up including patient reported outcomes using the MOST-S26 (measure of ovarian symptoms and treatment concerns) versus routine clinic based or telehealth follow-up, after completion of chemotherapy in patients with ovarian cancer
Annals of Oncology·2025
Radiotherapy versus imiquimod for complex lentigo maligna: A phase 3 randomized clinical trial
Journal of the American Academy of Dermatology·2025· 4 cited
Factors associated with the impact of the COVID-19 pandemic on Australians’ daily lives: the role of coping strategies
Psychology Health & Medicine·2025· 2 citedOpen Access
“The telehealth means I get distance from the hospital so I don’t feel so much like a patient”: A qualitative sub-study examining the acceptability of nurse-led follow-up for ovarian cancer via telehealth using the MOST-S26 to structure consultations.
Journal of Clinical Oncology·2025
Patient-reported outcomes (PROs) in locally advanced cervical cancer (LACC): Insights from the OUTBACK trial.
Journal of Clinical Oncology·2025· 2 cited
Shifting perspectives: a reflection on cancer-specific quality-of-life metrics in cancer care economics
The Lancet Oncology·2025· 1 citedOpen Access
Validation of the cancer-specific utility measure EORTC QLU-C10D using evidence from four lung cancer trials covering six country value sets
Scientific Reports·2025Open Access
Validation of the Cancer-Specific Preference-Based Measure EORTC QLU-C10D against the Generic Instruments EQ-5D-5L and SF-6Dv2 in a Prospectively Collected Sample of Patients with Cancer in Austria and France
PharmacoEconomics·2025· 2 citedOpen Access
Japanese value set for the Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D) cancer-specific preference-based quality of life instrument
2025Open Access
Development and psychometric evaluation of a patient-reported symptom index for patients with non-muscle invasive bladder cancer: the NMIBC-SI
Journal of Patient-Reported Outcomes·2025Open Access
Health-related quality of life in Singapore: Population norms for the EQ-5D-5L and EORTC QLQ-C30
Annals of the Academy of Medicine Singapore·2025· 5 citedOpen Access
Erratum to “Cancer-specific utility instrument for health economic evaluations: A synopsis of the EORTC QLU-C10D user manual and current validity evidence” [Eur J Cancer (2025) 115235]
European Journal of Cancer·2025Open Access
Prognostic significance and accuracy of oncologists’ estimates of survival time in recurrent ovarian cancer
International Journal of Gynecological Cancer·2024
Norwegian and Swedish value sets for the EORTC QLU-C10D utility instrument
Quality of Life Research·2024· 3 citedOpen Access
Health-Related Quality of Life in Adolescents and Young Adults Treated with Blinatumomab Consolidation for CD19+ Ph-Negative Acute Lymphoblastic Leukemia in the Australasian Lymphoma and Leukaemia Group (ALLG) ALL09 “Sublime” Study
Blood·2024Open Access
The Cancer-Specific Health Economic Measure QLU-C10D is Valid and Responsive for Assessing Health Utility in Patients with Thyroid Cancer
Thyroid·2024· 4 cited
SIOG2024-1-P-024 External validation of the ELFI v2.0: a patient-reported measure of functional status and frailty indicator in geriatric oncology
Journal of Geriatric Oncology·2024
page 1 of 22Next →

Frequent Co-authors

Andrew Bottomley(10), Galina Velikova(10), Corneel Coens(8), Hans‐Henning Flechtner(8), Melanie Calvert(7), Francesca Martinelli(7), Chantal Quinten(7), Rosalie Viney(7), Kim Cocks(6), Carolyn Gotay(6), Rebecca Mercieca‐Bebber(5), Julia Brown(5), Martin R. Stockler(5), Richard Norman(5), Charles S. Cleeland(5), Tim Luckett(5), Patricia Kenny(5), John Maringwa(5), Eva Greimel(5), Jolie Ringash(5)